Martin Georg Strebl-Bantillo

Title: Martin Georg Strebl-Bantillo: Innovator in HDAC6 Inhibitors and Imaging Agents

Introduction

Martin Georg Strebl-Bantillo is a notable inventor based in Somerville, MA, with a focus on developing innovative compounds for medical applications. He holds three patents that contribute significantly to the field of biochemistry and medical imaging. His work primarily revolves around histone deacetylase enzymes, which play a crucial role in various diseases.

Latest Patents

Strebl-Bantillo's latest patents include advancements in HDAC6 inhibitors and imaging agents. These patents provide compounds that are useful for binding to one or more histone deacetylase enzymes (HDACs). The applications also include radiolabeled compounds that serve as radiotracers for positron emission tomography imaging of HDAC. Furthermore, the patents detail methods for preparing both unlabeled and labeled compounds, diagnostic methods, and approaches for treating diseases associated with HDAC.

Career Highlights

Throughout his career, Martin has worked with reputable organizations, including The General Hospital Corporation and Studiengesellschaft Kohle GmbH. His contributions to these institutions have been instrumental in advancing research and development in his field.

Collaborations

Some of his notable coworkers include Jacob Matthew Hooker and Changning Wang, who have collaborated with him on various projects related to his patents and research.

Conclusion

Martin Georg Strebl-Bantillo is a distinguished inventor whose work on HDAC6 inhibitors and imaging agents has made a significant impact in the medical field. His innovative contributions continue to pave the way for advancements in diagnostic and therapeutic methods.